NDC 68094-754-01 - Morphine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68094-754
- Requested NDC
- 68094-754-01
- Package NDCs from labels
- 68094-754-01, 68094-754-58
- Manufacturer
- Precision Dose Inc.
- Effective date
- 2021-03-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Morphine Sulfate - Precision Dose Inc. | Precision Dose Inc. | 2021-03-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68094-754-01 | EA - Each | 68094-754 | 6d96baa8-43b4-4dea-8ba2-c7304569c4b1 | 1 | 2018-05-09 |
| 68094-754-58 | EA - Each | 68094-754 | 85668afd-dd03-4d19-9822-3e8f1e56420f | 1 | 2015-11-12 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 | |
| citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 | |
| edetate disodium | INACTIVE INGREDIENT | 7FLD91C86K | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 | |
| sodium benzoate | INACTIVE INGREDIENT | OJ245FE5EU | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 | |
| sorbitol | INACTIVE INGREDIENT | 506T60A25R | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Morphine Sulfate | MORPHINE SULFATE | Cranbury Pharmaceuticals, LLC | d8598654-94ad-4cfb-81d2-9b68e013a428 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Morphine sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | 07993f6c-146b-4728-a2da-6e93089f78ff | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Morphine Sulfate | MORPHINE SULFATE | American Health Packaging | 66a3f607-7f48-490f-84dd-b74dd1ee39e5 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Morphine Sulfate | MORPHINE SULFATE | Hikma Pharmaceuticals USA Inc. | ca359246-4674-4b32-b8b2-673d32b7112f | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | NDA022195 0054-0404 X3P646A2J0 |
| Morphine Sulfate | MORPHINE SULFATE | Hikma Pharmaceuticals USA Inc. | 3c847554-3b4b-4d24-a145-2ef7e9b83699 | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
| Morphine sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | 3a89d0ca-4ff8-4bdc-8ea8-9ad591ce7226 | 2026-01-22 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.